Celgene and Bristol-Myers are 2013 stock market winners
This article was originally published in Scrip
Executive Summary
Celgene’s stock outperformed all the biotech company’s big rivals in 2013 and Bristol-Myers Squibb was the best performer among large pharmaceutical makers.